会议专题

Increased Survival Time of a Patient with Metastatic Malignant Melanoma Following Immunotherapy:A Case Report and Literature Review

  Metastatic malignant melanoma is limited to the treatment of chemotherapy and radiotherapy.Nowadays, many studies have confirmed that Cytokine-induced killer cells (CIK cells) are heterogeneous cell populations that express CD3 and CD56 as well as the activation receptor of NK ceils (NKG2D), antigen.

张勇 宋永平 高全立

郑州大学附属肿瘤医院

国内会议

第九届中国肿瘤内科大会、第四届中国肿瘤医师大会暨中国抗癌协会肿瘤临床化疗专业委员会2015年学术年会

北京

英文

837-838

2015-07-01(万方平台首次上网日期,不代表论文的发表时间)